Sorted By:

Relevance


Codes & Guidelines

PhRMA  |  From PhRMA

Browse key Codes and Guidelines below, and visit our Resource Library for more.
https://www.phrma.org/about/codes-and-guidelines

Direct to Consumer Advertising Principles

PhRMA  |  Codes & Guidelines

The certification must be signed by the company’s Chief Executive Officer and Chief Compliance Officer for its United States pharmaceutical business.
https://www.phrma.org/codes-and-guidelines/direct-to-consumer-advertising-principles

The Value Collaborative

PhRMA  |  From PhRMA

View reports, comment letters, fact sheets and codes and guidelines explaining policy and regulatory changes that can help advance value-driven health care.
https://www.phrma.org

Code on Interactions With Health Care Professionals

PhRMA  |  Codes & Guidelines

PhRMA member companies’ relationships with clinical investigators and other individuals and entities as they relate to the clinical research process are addressed in the PhRMA Principles on Conduct of Clinical Trials and Communication of Clinical Trial Results.
https://www.phrma.org/codes-and-guidelines/code-on-interactions-with-health-care-professionals

BIO/PhRMA Principles on Responsible Sharing of Truthful and Non-Misleading Information about Medicines with Health Care Professionals and Payers

PhRMA  |  Codes & Guidelines

The Principles pertain primarily to data and information outside of FDA-approved labeling, and are intended to establish responsible, science-based parameters for accurate and trusted information sharing.
https://www.phrma.org/codes-and-guidelines/bio/phrma-principles-on-responsible-sharing-of-truthful-and-non-misleading-information-about-medicines-with-health-care-professionals-and-payers

PhRMA Principles for Responsible Clinical Trial Data Sharing – Certifications

PhRMA  |  Codes & Guidelines

Under these commitments to share clinical trial information, companies that follow the Principles certify that they have established policies and procedures to implement the data sharing commitments.
https://www.phrma.org/codes-and-guidelines/phrma-principles-for-responsible-clinical-trial-data-sharing-certifications

PhRMA Principles on Interactions with Patient Organizations

PhRMA  |  Codes & Guidelines

In our joint mission of innovation and service to patients and caregivers, companies frequently work together with patient organizations to sponsor research, provide educational and support services for patients, and award grants to benefit the mission of patient groups.
https://www.phrma.org/codes-and-guidelines/phrma-principles-on-interactions-with-patient-organizations

PhRMA Principles on Conduct of Clinical Trials

PhRMA  |  Codes & Guidelines

Many different entities and individuals contribute to the safe and appropriate conduct of clinical research, including not only sponsoring companies but also regulatory agencies; investigative site staff and medical professionals who serve as clinical investigators; hospitals and other institutions where research is conducted; and Institutional Review Boards and Ethics Committees.
https://www.phrma.org/codes-and-guidelines/phrma-principles-on-conduct-of-clinical-trials

PhRMA Principles for Payment and Delivery System Reforms

PhRMA  |  Codes & Guidelines

It is vital that pathways, guidelines, and value frameworks informing payment reforms support informed physician-patient decision-making from the range of treatment options and are based on well-researched, methodologically rigorous evidence.
https://www.phrma.org/codes-and-guidelines/phrma-principles-for-payment-and-delivery-system-reforms

Principles for Value Assessment Frameworks

PhRMA  |  Codes & Guidelines

Use rigorous methods and make them transparent to researchers and users: Methods for assessing value should be grounded in sound, recognized methods and be subject to meaningful and rigorous peer review.
https://www.phrma.org/codes-and-guidelines/principles-for-value-assessment-frameworks

PhRMA response to Washington Post and 60 Minutes stories

PhRMA  |  Blog Post

And we believe that Congress should consider whether existing criminal and civil penalties are sufficient for repeated failures of DEA registrants to ensure that they report suspicious orders for controlled substances in a timely manner.
http://catalyst.phrma.org/phrma-response-to-washington-post-and-60-minutes-stories

PhRMA Statement on Codes of Conduct

PhRMA  |  Press Release

Industry-wide research and investment reached a record $58.8 billion in 2007.
https://www.phrma.org/press-release/phrma-statement-on-codes-of-conduct

PhRMA Principles on Clinical Pathway Programs

PhRMA  |  Codes & Guidelines

Pathway Use: Consistent with PhRMA’s principles for payment and delivery reform, value-based payment models (e.g., those that provide financial incentives for use of clinical pathways) should be grounded in evidence and developed through an open and transparent process with opportunities for public and stakeholder input. 
https://www.phrma.org/codes-and-guidelines/phrma-principles-on-clinical-pathway-programs

Principles On Responsible Sharing of Truthful and Non-Misleading Information About Medicines with Health Care Professionals and Payers

PhRMA  |  Codes & Guidelines

The principles pertain primarily to data and information outside of FDA-approved labeling, and are intended to establish responsible, science-based parameters for accurate and trusted sharing. 
https://www.phrma.org/codes-and-guidelines/principles-on-responsible-sharing-of-truthful-and-non-misleading-information-about-medicines-with-health-care-professionals-and-payers

PhRMA Principles for Clinical Trial Data Sharing

PhRMA  |  Codes & Guidelines

Biopharmaceutical companies are committed to enhancing public health through responsible sharing of clinical trial data in a manner that is consistent with the following Principles: Safeguarding the privacy of patients Respecting the integrity of national regulatory syste...
https://www.phrma.org/codes-and-guidelines/phrma-principles-for-responsible-clinical-trial-data-sharing

ICYMI: Avalere and FasterCures develop new value framework from patient perspective

PhRMA  |  Blog Post

In addition to working with existing framework developers, such as the Institute for Clinical and Economic Review, American Society of Clinical Oncology and National Comprehensive Cancer Network, the PPVF initiative also plans to translate its framework into tools that can be used by patients and physicians to help guide treatment decisions.
http://catalyst.phrma.org/icymi-avalere-and-fastercures-develop-new-value-framework-from-patient-perspective

For a Healthier America: Strategies to Combat Prescription Drug Abuse

PhRMA  |  Codes & Guidelines

PhRMA and its members are committed to continuing to work with stakeholders in both the private and public sectors to address this complex and challenging public health issue.
https://www.phrma.org/codes-and-guidelines/for-a-healthier-america-strategies-to-combat-prescription-drug-abuse

Final Comments on Proposed Amendments to SIPO Patent Examination Guidelines (China)

PhRMA  |  Speeches & Communication

PhRMA, along with EFPIA, IFPMA, INTERPAT, and JPMA, issues final comments to the State Intellectual Property Office (SIPO) of China on the draft Patent Examination Guidelines ("Draft Guidelines").
https://www.phrma.org

Let's Talk About Cost

PhRMA  |  From PhRMA

Must-Know Facts About Medicine Costs and Spending: Download Here
https://www.phrma.org/advocacy/cost-and-value

Senior Manager – Policy and Research

PhRMA  |  PhRMA Career

We offer tuition reimbursement, industry on-site and off-site trainings, and management development programs. 
https://www.phrma.org/careers/sr-manager-policy-and-research

Senior Director - Science and Regulatory Advocacy (Drug Development Tools)

PhRMA  |  PhRMA Career

We are committed to the growth and development of our team members and offer many learning opportunities such as tuition reimbursement at both the undergraduate and graduate levels, industry on-site and off-site training, PhRMAcademy lunch and learn sessions, presentation skills, performance management and other management/professional develop programs. 
https://www.phrma.org/careers/senior-director-science-and-regulatory-advocacy

Associate Vice President – Science and Regulatory Advocacy (Biologics and Biosimilars Advocacy)

PhRMA  |  PhRMA Career

Developing and presenting project proposals and outputs to PhRMA leadership and leadership committees.
https://www.phrma.org/careers/associate-vice-president-science-and-regulatory-advocacy-biologics-and-biosimilars-advocacy

Senior Director – Science and Regulatory Advocacy (Drug Development Tools)

PhRMA  |  PhRMA Career

We are committed to the growth and development of our team members and offer many learning opportunities such as tuition reimbursement at both the undergraduate and graduate levels, industry on-site and off-site training, PhRMAcademy lunch and learn sessions, presentation skills, performance management and other management/professional develop programs.
https://www.phrma.org

Medicines in Development for Heart Disease & Stroke 2015

PhRMA  |  Report

According to the American Heart Association, someone in the United States dies from cardiovascular disease every 40 seconds, and more than 85 million Americans have at least one form of the disease.
https://www.phrma.org/report/medicines-in-development-for-heart-disease-and-stroke-2015-report

17 years (and more) of medical discoveries

PhRMA  |  Blog Post

Each and every one of these medical advancements has led me here, 17 years later, and science willing, many, many more.   
http://catalyst.phrma.org/17-years-and-more-of-medical-discoveries

You have reviewed the first 25 results out of 2497. Each page contains 25 results. You're on page 1.

prev 1 2 3 4 5 6 next